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“The Heart is Uno”: If AF begets HF and HF begets AF, can patients with concurrent 
incident AF and HF constitute an individual subgroup?  
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We have read with great interest the eloquent paper by Santhakrishna and 
colleagues demonstrating that among patients from the Framingham cohort with 
new AF, more than one third had HF at some point. Conversely, among patients with 
new HF, more than half had AF. This had major implications in prognosis, as patients 
affected by both conditions did worse in terms of mortality [1]. 
On a physiologic level, even though there is an atrial and a ventricular syncytium 
connected by a specialized electrical conduction system, due to the very close 
anatomic relations of these structures we tend to consider the heart as a single 
(“uno” – one) muscle. This has been neglected in cardiomyopathy classifications [2], 
but a recent concept of atrial cardiomyopathy with implications on prognosis has 
been emerging [3-4]. Therefore, in the future we may be speaking of primary atrial 
cardiomyopathies, ventricular cardiomyopathies and mixed cardiomyopathies. 
Imaging may provide more insights into atrial cardiomyopathies [5], as while some 
forms may be primarily electric (i.e. atrial channelopathies), in others forms there 
may be contribution of stretching, fibrosis, inflammation or other structural changes.  
Under that perspective, we can theoretically hypothesize that in this cohort, and 
according to what the authors have shown, AF begets HF (some of these patients 
may have forms of atrial cardiomyopathy that compromises LV function over time, 
progressing to global cardiomyopathy at a later stage) and the opposite. The authors 
have assessed patients with incident AF and patients with incident HF in separate. 
However, under that perspective, it would have been of interest to analyse a third 
and possibly different group of patients: the group of patients where AF and HF have 
developed in a very close temporal proximity (e.g. AF presenting with concurrent HF 
or HF developing in the first 30 days  - corresponding to 12% of AF diagnoses; and HF 
presenting with concurrent AF – corresponding to 18% of HF diagnoses) and who 
may possibly be representative of a global cardiomyopathy involving both atria and 
ventricles right from start. It would be of interest to know if this truly represents a 
different entity and whether or not the prognosis of these patients is different to 
that of patients who later progress to develop both conditions. Can this group of 
patients represent a more aggressive and generalized form of a cardiomyopathic 
involvement/process right ab initio (a true mixed cardiomyopathy) leading to a 
worse prognosis or is it just a fortuitous time occurrence where concurrent 
development of both conditions does not portrait a worse outcome? 
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